Search

Search Results

• TREATMENT WITH LOW-DOSE CYTARABINE IN ELDERLY PATIENTS (AGE 70 YEARS OR OLDER) WITH ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION EXPERIENCE

  Maël Heiblig, Mohamed Elhamri, Isabelle Tigaud, Adriana Plesa, Fiorenza Barraco, Hélène Labussière, Sophie Ducastelle, Mauricette Michallet, Franck Nicolini, Claudiu Plesa, Eric Wattel, Gilles Salles, Xavier Thomas

  e2016009

  2016-01-01

  https://doi.org/10.4084/mjhid.2016.009

  7443

  PDF: 1526

  HTML: 1654

• GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

  Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau

  e2011019

  2011-05-16

  https://doi.org/10.4084/mjhid.2011.019

  2619

  PDF: 815

  HTML: 5240

• RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES

  Julie Schanz, Friederike Braulke, Detlef Haase

  e2015034

  2015-04-23

  https://doi.org/10.4084/mjhid.2015.034

  3844

  PDF: 1688

  HTML: 11652

  Figures Haase: 212

• PROGNOSTIC IMPACT OF WT-1 GENE EXPRESSION IN EGYPTIAN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

  Adel Abd Elhaleim Hagag

  e2016008

  2016-01-01

  https://doi.org/10.4084/mjhid.2016.008

  4126

  PDF: 847

  HTML: 2431

• ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS

  saveria capria, silvia maria trisolini, clara minotti, caterina stefanizzi, luisa cardarelli, Martina Canichella, claudio cartoni, daniela diverio, maria stefania de propris, marco mancini, alessandra micozzi, robin foà, giovanna meloni

  e2012072

  2012-11-06

  https://doi.org/10.4084/mjhid.2012.072

  1714

  PDF: 828

  HTML: 939

  cover letter: 274

• A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA

  Michele Baccarani, Fabrizio Pane

  e2014010

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.010

  3279

  PDF: 1358

  HTML: 4144

• Leukemia cutis in a patient with acute myeloid leukemia undergoing Azacitidine-Venetoclax: case presentation and review of the literature

  Elisa Buzzatti, Cristina Mauro, Caterina Botti, Roberta Presicci, Giovangiacinto Paterno, Raffaele Palmieri, Carmelo Gurnari, Flavia Mallegni, Elisa Meddi, Federico Moretti, Lucia Cardillo, Valeria Mezzanotte, Kristian Taka, Lucrezia De Marchi, Luca Maurillo, Francesco Buccisano, Adriano Venditti, Maria Ilaria Del Principe

  e2025013

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.013

  1016

  PDF: 1128

  HTML: 122

• THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA

  Yingying Li, Yang Li, Wenguo Cheng

  e2025073

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.073

  514

  PDF: 255

  HTML: 80

• A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.

  Roula Antoine Farah

  e2015012

  2014-12-27

  https://doi.org/10.4084/mjhid.2015.012

  2127

  PDF: 1136

  HTML: 7714

  cover letter paper final AML: 227

• TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML

  Buket Altinok Gunes, Tulin OZKAN, Aynur Karadag Gurel, Semih Dalkilic, Nevin Belder, Zeynep Ozkeserli, Hilal Ozdag Sevgili, Meral Beksac, Nilgun Sayinalp, Abdullah Munci Yagci, Asuman Sunguroglu

  e2024058

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.058

  1078

  PDF: 1186

  Suppl. Files: 571

  HTML: 92

• THERAPEUTIC OPTIONS FOR PATIENTS WHO ARE NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY

  Elihu Estey

  e2013050

  2013-07-12

  https://doi.org/10.4084/mjhid.2013.050

  2200

  PDF: 756

  HTML: 1635

• BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN

  Maria Teresa Voso, Giulia Falconi, Dr. Fabiani

  e2023055

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.055

  1836

  PDF: 1000

  HTML: 147

• Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF

  Wen Yao, Xinchen Fang, Peng Jiang, Juan Tong, Liangquan Geng, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Kaidi Song, Lei Zhang, Ping Qiang, Guangyu Sun, Yongsheng Han, Huilan Liu, Zimin Sun

  e2022025

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.025

  1803

  PDF: 586

  HTML: 302

• A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY

  Prateek bhatia, Jogeshwar Binota, Neelam Varma, Deepak Bansal, amita trehan, Ram Kumar Marwaha, Pankaj Malhotra, Subhash Varma

  e2012024

  2012-05-03

  https://doi.org/10.4084/mjhid.2012.024

  1384

  PDF: 849

  HTML: 5043

  INSTITUTE PUBLICATION COMMITTEE APPROVAL: 165

• SEROLOGICAL CHANGES AGAINST HEPATITIS B SURFACE ANTIGEN IN CHILDREN AND ADOLESCENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIA

  Seung Beom Han, Hye Jo Shin, Eui Soo Lee, Jae Wook Lee, Nack-Gyun Chung, Bin Cho, Jin Han Kang

  e2019052

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.052

  1190

  PDF: 804

  HTML: 194

• PROGNOSTIC IMPACT OF NEUROPILIN-1 EXPRESSION IN EGYPTIAN CHILDREN WITH B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA

  adel abd elhaleim hagag, Nahla A Nosair

  e2015009

  2014-12-28

  https://doi.org/10.4084/mjhid.2015.009

  1669

  PDF: 838

  HTML: 2118

• MOLECULAR HETEROGENEITY IN ACUTE PROMYELOCYTIC LEUKEMIA - A SINGLE CENTRE EXPERIENCE FROM INDIA

  Nikhil Rabade, Goutham Raval, Shruti Chaudhary, PG Subramanian, Rohan Kodgule, Swapnali Joshi, Prashant Tembhare, Hasmukh Jain, Manju Sengar, Syed Hasan K, Pratibha Amare Kadam, Dhanalaxmi Shetty, Gaurav Narula, Shripad Banavali, Sumeet Gujral, Nikhil Patkar

  e2018002

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.002

  3679

  PDF: 1220

  HTML: 1106

• EXTRAMEDULLARY INVOLVEMENT IN ACUTE MYELOID LEUKEMIA. A SINGLE CENTER TEN YEARS EXPERIENCE

  Luana Fianchi, Martina Quattrone, Marianna Criscuolo, Silvia Bellesi, Giulia Dragonetti, Alessio Maria Edoardo Maraglino, Matteo Bonanni, Patrizia Chiusolo, Simona Sica, Livio Pagano

  Page e2021030

  2021-04-29

  https://doi.org/10.4084/MJHID.2021.030

  2474

  PDF: 898

  HTML: 384

• THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies

  Emine Atli, Rasime Kalkan, Cisem Mail, Damla Eker, Ufuk Demirci, Selma Demir, Sinem Yalcintepe, Hakki Onur Kirkizlar, Engin Atli, Hakan Gurkan, Ahmet Muzaffer Demir

  e2021013

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.013

  1593

  PDF: 559

  HTML: 294

• Massive pulmonary embolism at the onset of acute promyelocytic leukemia

  Federica Sorà, Patrizia Chiusolo, Luca Laurenti

  e2016027

  2016-07-01

  https://doi.org/10.4084/mjhid.2016.027

  3549

  PDF: 906

  HTML: 1665

  figure 1: 171

  Untitled: 197

• SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs

  Massimo Breccia, Giuliana Alimena

  e2014003

  2014-01-02

  https://doi.org/10.4084/mjhid.2014.003

  3312

  PDF: 1233

  HTML: 3476

• THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

  Xenofon Papanikolaou, Bart Barlogie, Saad Usmani

  e2011047

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.047

  2504

  PDF: 798

  HTML: 1741

• EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES

  Kjeld Schmiegelow

  e2011020

  2011-05-16

  https://doi.org/10.4084/mjhid.2011.020

  2258

  PDF: 829

  HTML: 1639

  Figure 1: 203

  Table 1: 220

• THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML

  Dr. Palmieri, Ilaria Del Principe, Dr. Maurillo, Prof. Venditti, Francesco Buccisano

  e2023051

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.051

  1778

  PDF: 829

  HTML: 178

• INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE

  Duni Sawadogo, Aissata Tolo, Hermance Kassi, Mahawa Sangare, Andre Inwoley

  e2013023

  2013-04-10

  https://doi.org/10.4084/mjhid.2013.023

  2019

  PDF: 739

  HTML: 689

  Table1: patient's characteristics: 160

  Table 2: profile of each patient: 184

• VACCINATION FOLLOWING LEUKEMIA TREATMENT: VIRAL VACCINE RESPONSES IN SURVIVORS OF ACUTE LYMPHOBLASTIC LEUKEMIA

  Elif Kilic Konte, Ayca Koca Yozgat, Aysun Kara Uzun, Bahar Cuhaci Cakir, Nese Yarali

  e2025049

  2025-06-29

  https://doi.org/10.4084/MJHID.2025.049

  844

  PDF: 578

  HTML: 34

• INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA

  Sutatta Supatharawanich, Nattee Narkbunnam, Nassawee Vathana, Chayamon Takpradit, Kamon Phuakpet, Bunchoo Pongtanakul, Sasima Tongsai, Phakatip Sinlapamongkolkul, Popchai Ngamskulrungroj, Wanatpreeya Phongsamart, Kleebsabai Sanpakit , Jassada Buaboonnam

  e2021039

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.039

  2778

  PDF: 909

  HTML: 235

• TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS

  Eleonora De Bellis, Luana Fianchi, Francesco Buccisano, Marianna Criscuolo, Luca Maurillo, Laura Cicconi, Mattia Brescini, Maria Ilaria Del Principe, Ambra Di Veroli, Adriano Venditti, Francesco Lo-Coco, Maria Teresa Voso

  e2017045

  2017-07-01

  https://doi.org/10.4084/mjhid.2017.045

  4408

  PDF: 1780

  HTML: 1111

• EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA

  Linjuan Xu

  e2025058

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.058

  1505

  PDF: 795

  Suppl. Files: 332

  Html: 140

• CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP

  Alessandro Laganà, Matteo Totaro, Maria Laura Bisegna, Loredana Elia, Stefania Intoppa, Marco Beldinanzi, Mabel Matarazzo, Mariangela di Trani, Alessandro Costa, Raffaele Maglione, Biancamaria Mandelli, Sabina Chiaretti, Maurizio Martelli, Maria Stefania De Propris

  e2024064

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.064

  1329

  PDF: 814

  Suppl. Files: 469

  Html: 109

• BASELINE THROMBIN GENERATION TEST DOES NOT PREDICT THROMBOTIC EVENTS IN ACUTE LEUKEMIA: A MONOCENTRIC PROSPECTIVE STUDY

  Mario Biglietto, Rosaria Mormile, Maria Laura Bisegna, Alessandro Laganà, Anna Laura Faccini, Andrea Papa, Erminia Baldacci, Cristina Santoro, Maria Stefania De Propris, Antonio Chistolini

  e2025076

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.076

  417

  PDF: 201

  Html: 57

• Severe acute axonal neuropathy following treatment with arsenic trioxide for acute promyelocytic leukemia: a case report

  Marcus Kuhn, Mithia Nabergoj, Kety Sammartin, Fabrizio Vianello

  e2016023

  2016-05-01

  https://doi.org/10.4084/mjhid.2016.023

  4104

  PDF: 1017

  HTML: 1571

• INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY

  Giuseppe Leone, Livio Pagano

  e2018039

  2018-07-01

  https://doi.org/10.4084/mjhid.2018.039

  4240

  PDF: 1466

  HTML: 613

• LUMBAR PUNCTURE: A CROSS-SECTIONAL STUDY USING THE CHINESE VERSION OF THE STATE ANXIETY SCALE FOR CHILDREN.

  Xiuli Qin, Xin Zhao, Ting Zhou, Danyan Yang, Genzhen Yu

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.021

  615

  PDF: 480

  HTML: 84

• CLINICAL FEATURES AND CLINICAL OUTCOME OF ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS TREATED AT CAIRO NATIONAL CANCER INSTITUTE IN EGYPT

  Ola Khorshid, Amira Diaa, Mohamed Abd El Moaty, Rafat Abd El Fatah, Ihab El Dessouk, Maha Abd El Hamid, Essam El Noshokaty, Ghada El Saied, Tamer M Fouad, Safaa M Ramadan

  e2011060

  2011-12-07

  https://doi.org/10.4084/mjhid.2011.060

  3084

  PDF: 970

  HTML: 2299

• ACUTE LYMPHOBLASTIC LEUKEMIA EXPERIENCE: EPIDEMIOLOGY AND OUTCOME OF TWO DIFFERENT REGIMENS

  Salah Abbasi, Faten Maleha, Muhannad Shobaki

  e2013024

  2013-04-10

  https://doi.org/10.4084/mjhid.2013.024

  2074

  PDF: 1041

  HTML: 2624

• EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA

  Li Zhang, Xiaofan Zhu

  e2012012

  2012-03-10

  https://doi.org/10.4084/mjhid.2012.012

  2405

  PDF: 852

  HTML: 2161

  New table Chinese children with APL: 164

• NG2 MOLECULE EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA B CELLS: A FLOW-CYTOMETRIC MARKER FOR THE RAPID IDENTIFICATION OF KMT2A GENE REARRANGEMENTS

  Maria Laura Bisegna, Nadia Peragine, Loredana Elia, Mabel Matarazzo, Maria Laura Milani, Stefania Intoppa, Mariangela Di Trani, Francesco Malfona, Maurizio Martelli, Maria Stefania De Propris

  e2024018

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.018

  992

  PDF: 1297

  Suppl. Files: 833

  HTML: 180

• TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN

  Ramzi Jeddi, Hèla Ghédira, Ramzi Ben Amor, Yosr Ben Abdennebi, Kacem Karima, Zarrouk Mohamed, Hend Ben Neji, Lamia Aissaoui, Raihane Ben Lakhal, Naouel Ben Salah, Samia Menif, Zaher Belhadjali, Hela Ben Abid, Emna Gouider, Raouf Hafsia, Ali Saad, Pierre Fenaux, Balkis Meddeb

  e2011033

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.033

  3998

  PDF: 763

  HTML: 1857

• MICRORNA-181A-3P AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER FOR ACUTE MYELOID LEUKEMIA

  Xiaoling Ma

  e2020012

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.012

  1720

  PDF: 1049

  HTML: 216

• ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

  Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante

  e2022008

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.008

  2335

  PDF: 1180

  HTML: 654

• DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia

  Buket Altinok Gunes, Yalda Hekmatshoar, Tulin Ozkan, Sureyya Bozkurt, O.Sena Aydos, Yahya Buyukasik, Elifcan Aladag, Asuman Sunguroglu

  e2023008

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.008

  1366

  PDF: 1251

  HTML: 463

• IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy

  İbrahim Halil Açar, Sebnem Izmir Güner , Muzeyyen Aslaner Ak, Mesut Gocer, Erman Ozturk , Figen Atalay, Gulden Sincan , Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Emine Gulturk , Nazli Demir, Ali Dogan, Yildiz Ipek, Birol Guvenc

  e2022074

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.074

  1583

  PDF: 803

  HTML: 221

• FEVER OF UNKNOWN ORIGIN AND MULTIDRUG-RESISTANT ORGANISMS COLONIZATION IN AML PATIENTS.

  Luca Guarnera, Gentiana Elena Trotta, Valentina Boldrini, Lucia Cardillo, Ilaria Cerroni, Valeria Mezzanotte, Gianmario Pasqualone, Arianna Savi, Beatrice Borsellino, Elisa Buzzatti, Raffaele Palmieri, Giovangiacinto Paterno, Luca Maurillo, Francesco Buccisano, Adriano Venditti, Maria Ilaria Del Principe

  e2023013

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.013

  2172

  PDF: 1170

  HTML: 476

• Late-onset hepatic veno-occlusive disease after allografting: report of two cases with atypical clinical features successfully treated with defibrotide.

  Alessia Castellino, Stefano Guidi, Chiara Dellacasa, Antonella Gozzini, Irene Donnini, Chiara Nozzoli, Sara Manetta, Semra Aydin, Luisa Giaccone, Moreno Festuccia, Lucia Brunello, Enrico Maffini, Benedetto Bruno, Ezio David, Alessandro Busca

  e2018001

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.001

  4215

  PDF: 1137

  HTML: 999

• Osteolytic bone lesions – A rare presentation of AML M6.

  Geetha N., Sreelesh KP, Priya Mary Jacob, Lali VS, Rekha A Nair

  e2015017

  2015-02-12

  https://doi.org/10.4084/mjhid.2015.017

  2014

  PDF: 1119

  HTML: 7951

  Untitled: 206

• Prevention of Early Death in Very Elderly Acute Promyelocytic Leukemia Patients Using Lower Induction Doses of All-trans Retinoic Acid

  Mark Dalgetty, Sruthi Dontu, Chandini Kannan, Amany Keruakous, Locke Bryan, Vamsi Kota, Anand Jillella

  e2025066

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.066

  949

  PDF: 641

  Html: 140

• HOW I TREAT FEBRILE NEUTROPENIA

  Marcio Nucci

  e2021025

  2021-02-26

  https://doi.org/10.4084/mjhid.2021.025

  6881

  PDF: 3969

  HTML: 446

• AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA STILL A VALID TREATMENT OPTION, OR IS THE GAME OVER ?

  Fabienne McClanahan, Peter Dreger

  e2012071

  2012-11-06

  https://doi.org/10.4084/mjhid.2012.071

  2527

  PDF: 828

  HTML: 1694

• T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections

  Muhamad R. Abdel Hameed, Sherein G. Elgendy, Mohamed A El-Mokhtar, Douaa Sayed, Samar M. Mansour, Abeer M. Darwish

  e2022022

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.022

  1821

  PDF: 718

  HTML: 409